Company to Spotlight Comprehensive Hip & Knee Portfolios and Latest Advancements in Robotics, Including the mBôs™ System Following Recent Acquisition of Monogram Technologies WARSAW, Ind., Oct. 21, ...

The patient campaign is part of an effort to take Zimmer from being a company in ‘remediation mode’ and regain market share losses.

Argus Research has upgraded Zimmer Biomet Holdings Inc. (NYSE:ZBH) on launching new products and tuck-in M&A to build future growth drivers. One such driver is the ROSA system, which assists in ...

Zimmer Biomet provided 2025 guidance of constant currency revenue growth between 3%-5% and adjusted EPS in the range of $8.15 to $8.35. These projections exclude the impact of the Paragon 28 ...

Zimmer Biomet's ZBH strategic product launches and stabilizing market trends bolster our confidence in this stock. However, factors like macroeconomic uncertainties put pressure on the bottom line.

Zimmer Biomet announced plans to continue developing its robotic platforms and investing in a stronger, specialised sales force in the US.

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopedic reconstructive products; sports ...

Zimmer Biomet recently announced entering a definitive agreement to acquire all outstanding common shares of Paragon 28. Under the agreement, Zimmer Biomet will pay $13.00 per share, valuing Paragon ...

On Wednesday, Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported third-quarter adjusted EPS of $1.74, up from $1.65 a year ago, in line with the Street estimates. The orthopedic giant reported sales of ...